Posted by Michael Wonder on 10 Dec 2021
International regulators stress continued need for COVID-19 therapeutics
11 December 2021 - EMA has endorsed a statement by the International Coalition of Medicines Regulatory Authorities that urges all stakeholders, including researchers, pharmaceutical industry, healthcare professionals, health research funding agencies and research institutions, to continue their focus on developing therapeutics to treat and prevent COVID-19 in patients around the world.
The development of a joint statement on the importance of continued focus on COVID-19 treatments followed a series of meetings and discussions among International Coalition of Medicines Regulatory Authorities members on regulatory requirements to enable rapid development, approval and global roll-out of safe and efficacious medicines against COVID-19.
